Categories: Business

Novartis nears $70-plus per share deal to acquire Avidity Biosciences, Bloomberg News reports

(Reuters) -Swiss drugmaker Novartis AG is close to acquiring U.S. biotech Avidity Biosciences for over $70 per share, Bloomberg News reported on Sunday, citing a person familiar with…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by NewsX Syndication
Published: October 26, 2025 20:55:20 IST

(Reuters) -Swiss drugmaker Novartis AG is close to acquiring U.S. biotech Avidity Biosciences for over $70 per share, Bloomberg News reported on Sunday, citing a person familiar with the matter. Reuters could not immediately confirm the report. (Reporting by Dheeraj Kumar in Bengaluru; Editing by Aidan Lewis)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by NewsX Syndication
Published: October 26, 2025 20:55:20 IST

Recent Posts

Bridgerton Season 4: The Meaning Of ‘Ward’ And Painful Secret Behind Sophie Baek’s Past- Explained

Bridgerton Season 4 reveals the true meaning of “ward” and the painful secret behind Sophie…

January 30, 2026

How Did Amazon Detect So Much Child Sexual Abuse Material In Its AI Training Data?

Amazon detected hundreds of thousands of child sexual abuse cases in AI training data, raising…

January 30, 2026

After Maduro’s Capture, Trump Orders Reopening Of Venezuela Airspace, Americans Soon Able To Travel

US President Donald Trump announced that the United States will soon reopen commercial airspace over…

January 30, 2026